Redwood Pharma AB announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating income was SEK 6.980 million compared to SEK 3.594 million a year ago. net loss was SEK 6.981 million compared to SEK 3.594 million a year ago. for the half year, operating income was SEK 10.915 million compared to SEK 8.025 million a year ago. Net loss was SEK 11.276 million compared to SEK 8.026 million a year ago.